repository
대장암에서 AKT/mTOR 경로를 통한 옥살리플라틴 내성 발현에 관한 연구
| DC Field | Value | Language |
|---|---|---|
| dc.contributor.advisor | 김소희 | - |
| dc.contributor.author | 박선영 | - |
| dc.date.accessioned | 2022-11-29T02:32:04Z | - |
| dc.date.available | 2022-11-29T02:32:04Z | - |
| dc.date.issued | 2020-02 | - |
| dc.identifier.other | 29688 | - |
| dc.identifier.uri | https://dspace.ajou.ac.kr/handle/2018.oak/19565 | - |
| dc.description | 학위논문(석사)--아주대학교 일반대학원 :약학과,2020. 2 | - |
| dc.description.tableofcontents | ABSTRACT i TABLE OF CONTENTS ii LIST OF FIGURES iv LIST OF TABLES vi ABBREVIATIONS vii I. INTRODUCTION 1 II. MATERIALS AND METHOD 3 A. Chemicals 3 B. Cell culture and establishment of oxaliplatin-resistant cells 3 C. Cell proliferation assay 4 D. Flow cytometry analysis 4 E. Immunofluorescence analysis 5 F. Immunoblot analysis 5 G. Statistical analysis 6 III. RESULTS 7 A. Oxaliplatin-resistance of colon cancer cells 7 B. Drug efflux pump protein expression 10 C. Induction of cell cycle arrest by oxaliplatin 12 D. Protein expression on apoptosis and cell cycle 15 E. Induction of autophagy by oxaliplatin 17 F. Effect of oxaliplatin-resistance on AKT/mTOR pathway 19 G. Effect of oxaliplatin-resistance on glucose metabolism 21 IV. DISCUSSION 23 V. CONCLUSIONS 26 REFFERENCES 28 KOREAN ABSTRACT 33 | - |
| dc.language.iso | eng | - |
| dc.publisher | The Graduate School, Ajou University | - |
| dc.rights | 아주대학교 논문은 저작권에 의해 보호받습니다. | - |
| dc.title | 대장암에서 AKT/mTOR 경로를 통한 옥살리플라틴 내성 발현에 관한 연구 | - |
| dc.title.alternative | Sun Young Park | - |
| dc.type | Thesis | - |
| dc.contributor.affiliation | 아주대학교 일반대학원 | - |
| dc.contributor.alternativeName | Sun Young Park | - |
| dc.contributor.department | 일반대학원 약학과 | - |
| dc.date.awarded | 2020. 2 | - |
| dc.description.degree | Master | - |
| dc.identifier.localId | 1138640 | - |
| dc.identifier.uci | I804:41038-000000029688 | - |
| dc.identifier.url | http://dcoll.ajou.ac.kr:9080/dcollection/common/orgView/000000029688 | - |
| dc.subject.keyword | AKT-mTOR | - |
| dc.subject.keyword | LC3B | - |
| dc.subject.keyword | chemoresistance | - |
| dc.subject.keyword | colon cancer | - |
| dc.subject.keyword | oxaliplatin | - |
| dc.description.alternativeAbstract | Oxaliplatin is a third-generation platinum analog that can interfere with DNA replication and transcription by DNA damage. Continuous exposure of oxaliplatin resulted in resistance to oxaliplatin but no mechanisms of oxaliplatin-resistance were reported. In this study, oxaliplatin resistant cells were established using HCT116, HT29, SW480 and SW620 colon cancer cells by gradually increasing drug concentration up to a maximum of 2 µM at least for 3 month. The 50% inhibitory concentrations of cell growth (IC50) of oxaliplatin were 5.34, 9.88, 10.1 and 9.49-fold higher in oxaliplatin resistant HCT116, HT29, SW480, and SW620 cells, respectively, compared to their respective parental cells. One mechanism is that the expression of AKT and mTOR proteins were overexpressed in the oxaliplatin-resistant colon cancer cells. In addition, the expression of LC3B, an autophagy marker, decreased along with increasing AKT/mTOR signals, which caused the increase in glucose metabolism to produce energy for cell survival in oxaliplatin-resistant cancer cells. Taken together, oxaliplatin-resistance might be mediated through the activation of AKT/mTOR pathway in colon cancer cells, and AKT/mTOR might be a potential targets for oxaliplatin-resistance in human colon cancers. | - |
- Appears in Collections:
- Graduate School of Ajou University > Department of Pharmacy > 3. Theses(Master)
- Files in This Item:
- There are no files associated with this item.
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.
-
- License
- STATISTICS
- Total Visit :3,550,645
- Total Download :1,795
- Today View :13,010
